Baricitinib exposure during pregnancy in rheumatoid arthritis

We here describe the case of a 43-year-old White woman who was diagnosed with rheumatoid arthritis treated with anti-tumour necrosis factor drugs that caused an adverse drug reaction. The objective of this study was to describe the outcome of a pregnancy under baricitinib, a JAK-inhibitor drug, in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Costanzo, Giulia, Firinu, Davide, Losa, Francesca, Deidda, Margherita, Barca, Maria P., Del Giacco, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997965/
https://www.ncbi.nlm.nih.gov/pubmed/32071617
http://dx.doi.org/10.1177/1759720X19899296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997965/
https://www.ncbi.nlm.nih.gov/pubmed/32071617
http://dx.doi.org/10.1177/1759720X19899296

Ejemplares similares